Concepedia

Publication | Closed Access

IMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective study.

33

Citations

0

References

2010

Year

Lin Wang, Haigang Li, Zhong‐Sheng Xia, Jun Lü, Tingsheng Peng
PubMed

Abstract

Increase of IMP3 expression suggests that IMP3 may play an importent role in the carcinogenesis and tumor metastasis in GAC. It could be regarded as a novel proliferation and prognostic indicator for patients with GAC.